Experts highlight biotechnology's potential to drive sustainable growth and career opportunities in India's emerging ...

The Touchstone Dynamic Large Cap Growth Fund outperformed its benchmark in Q4 2025. Explore the full performance breakdown ...

Michael Yee, global head of biotech research at UBS, joins CNBC’s ‘Squawk on the Street’ to explain Moderna's narrower-than-expected loss, why healthcare is outperforming, and vaccine mandates and ...

Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.

Explore India's potential in bio-based chemicals and enzymes, highlighting industry leaders and challenges in sustainable ...

Capcom and biotech art group LOM BABY bring Resident Evil’s T-virus to Shibuya PARCO, explaining the exhibit, safety claims, and real biotech context ...

Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. | Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as ...

Discover India's Biopharma Shakti initiative: a ₹10,000-crore plan to enhance biologics, biosimilars, and healthcare standards.

Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...

BaseLaunch, a platform partnering with scientists and entrepreneurs to launch, fund, and build early biotech ventures, ...

The Ethereum co-founder argues that prediction markets’ current focus on short-term crypto bets is putting them on a path to ...

In an era of escalating biological threats, from weaponized pathogens to evolving viruses like Mpox, small U.S. biotechs are stepping up to bolster military readiness and national security.